Update on the Quality Round will be issued later this week. We are currently clearing a backlog of GAiT internal administrative issues. Thanks for your patience.
The number of autologous products under clinical development is likely to cause a strain on #QC provision. Listen to this webinar on demand as Head of Quality Control Doli Patel considers some the challenges #webinar - https://t.co/orXn1sETRu
Pluripotent Stem Cells Manufacturing Expert Panels 2019: audio recordings and slides from yesterday's event can be accessed by GAiT members at https://t.co/CbkfFrpKgj . Thanks to all Chairs/Participants.
We will be livestreaming the PSC Manufacturing Expert Panels 2019 tomorrow. See the agenda at https://t.co/CbkfFrpKgj and see start time in different time zones at https://t.co/uJfOfggacu
Logistical Challenges facing PSC/iPSC manufacturing and how to surmount them: Dr Simon Ellison of World Courier @ PSC Manufacturing Expert Panels 2019
IPSCs for off-the-shelf therapies? #stemcells #cancer
Eric Topol on Twitter
“"Universal" induced pluripotent stem cell therapy? A clinical trial in #cancer is underway https://t.co/GKvY80TZ94 @CellPressNews by @Catalytic...
GAiT and collaborators (ISCT, CIRM, HESI CT-TRACS & ISCBI) will host a series of Expert Panels on topics pertinant to the manufacture of human Pluripotent Stem Cells 30 JUNE 2019 in L.A. The event will be live-streamed & also edited recordings will be posted on our websites
GAiT will have multiple speakers at this event in September 2019
Phacilitate on Twitter
“Early Bird tickets are now available for #PLE2019! Register your place today: https://t.co/f3l7j5yv3I #europe #advancedtherapies #celltherapy...
It was GAiT's honour to describe rationale for, & design of, the iPSC Quality Round 2019 at #ISCT2019, listing all Organizers and Participants. We are grateful to @ISCTglobal (International Society for Cell and Gene Therapy) for allowing us describe this important initiative.
Defining, and testing for, quality of iPS cells at #ISCT2019. This morning discussed in the context of animal and pre-clinical studies.
Verifying induced pluripotent stem cell lines are the starting material needed for allogeneic therapeutic development. GAiT will be speaking about the iPSC Quality Round 2019 at the Plenary Hall at #ISCT2019 today 15.45 AEST.
Register for Pluripotent Stem Cell Manufacturing - Expert Panel Discussion 30 JUNE 2019
Pluripotent Stem Cell Manufacturing Meeting - Expert Panel Discussion
Pluripotent Stem Cell Manufacturing Meeting 2019
Michael May underlines the importance of scientific excellence and collaborative spirit to bringing new cell and gene therapies to the clinic #ISCT2019